BITTER EXTRA

Three-component crop protection: why Bitter Extra stands out

Managing sugar and fodder beet crops requires precision, as weeds compete aggressively with emerging seedlings, yet the crop remains sensitive to harsh chemical treatments. The Spanish herbicide Bitter Extra from Laboratorios Alcotan S.A. offers a balanced, professional-grade solution based on the synergy of three active ingredients: desmedipham, phenmedipham, and ethofumesate.

The mechanism behind the effectiveness

The primary advantage of Bitter Extra lies in its multi-pathway approach. While desmedipham and phenmedipham act rapidly to block photosynthesis in young broadleaf weeds through leaf absorption, ethofumesate provides a crucial residual soil effect. This is particularly valuable in varying moisture conditions, as the herbicide not only eliminates existing weeds but also suppresses subsequent flushes.

Performance and application benefits

• Selectivity: Specifically engineered for beet crops, the formula ensures high weed control while maintaining crop safety, provided the application protocols are strictly followed.
• Efficiency: As an emulsifiable concentrate, it ensures excellent coverage and rapid uptake. Being a selective, systemic, post-emergence herbicide, it is most effective when applied at the stage of the first to third true leaf pairs of the weeds.
• Reliability: Unlike purely contact-based analogues, the systemic properties of Bitter Extra allow for deeper penetration into weed metabolism, resulting in more consistent performance even under challenging environmental conditions.

Bitter Extra is an essential tool for intensive farming. Its efficacy depends significantly on timing; missing the optimal weed growth stage can reduce performance. However, for growers prioritizing clean fields and predictable yields, this Spanish-formulated herbicide remains an industry benchmark for performance-to-cost ratio. Choosing a product from Laboratorios Alcotan S.A. is a strategic decision for those who value European quality and proven formulation stability over unpredictable generics.